Method approaches to assessing the adaptation potential of the industrial pharmaceutical enterprise to changing economic conditions

Abstract

The aim of the article is to develop a methodology for assessing the potential of IPE adaptation to changes in external conditions and internal influencing factors.
 Materials and methods. The research used the methods of theoretical generalization, analysis and synthesis, correlation analysis and expert survey.
 Results. It is proposed to define the essence of the adaptation potential of an industrial pharmaceutical enterprise to changes in business conditions, under which it is appropriate to understand the enterprise's readiness to respond flexibly, quickly, and adequately to changes occurring in the external and internal environment, in order to increase its level of competitiveness. A technique for determining the level of industrial adaptation potential (the technique cannot be a model; the technique is stages that are related to each other) and a ranking model by its degree by parametrization is proposed. Based on the study of scientific works and the experience of global companies, it was determined that the model for ranking the level of adaptation potential by parameterization involves ranking elements according to the degree of readiness of the management system of an industrial pharmaceutical enterprise for adaptation. The components of parameters for assessing the adaptation potential of an industrial pharmaceutical enterprise have been formed. The limits of adaptation potential are defined.
 Conclusions. A methodology for assessing the adaptation potential of industrial pharmaceutical enterprises to the influence of external factors (martial law, the outflow of qualified personnel, a decrease in the purchasing power of the population, etc.) and taking into account the internal capabilities of the enterprise (resources (material, financial, labour, information, service, etc.), organizational structure and management decision-making) with the aim of increasing the competitiveness of the enterprise and its fulfilment of the social component of functioning, namely timely provision of the population with high-quality medicines in full in the right place at affordable prices.